SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $322,245,820 |
| Positions | 43 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| RELMADA THERAPEUTICS INC | RLMD | COM | $50,862,000 | 7,350,000 |
| C4 THERAPEUTICS INC | CCCC | COM STK | $33,624,000 | 7,200,000 |
| COGENT BIOSCIENCES INC | COGT | COM | $33,475,500 | 865,000 |
| KODIAK SCIENCES INC | KOD | COM | $19,480,000 | 500,000 |
| RELAY THERAPEUTICS INC | RLAY | COM | $18,148,700 | 970,000 |
| ZENTALIS PHARMACEUTICALS INC | ZNTL | COM | $17,945,000 | 3,700,000 |
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $11,782,700 | 290,000 |
| MAZE THERAPEUTICS INC | MAZE | COM | $9,996,400 | 335,000 |
| INVENTIVA SA | IVA | ADS | $9,204,300 | 2,435,000 |
| ADLAI NORTYE LTD | ANL | SPONSORED ADS | $8,796,074 | 764,876 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.